Wednesday, August 20th, 2014

DUBLIN, IRELAND -- (Marketwired) -- Research and Markets (http://www.researchandmarkets.com/research/mcdz7t/in_vitro) has announced the addition of the "In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2019" report to their offering.

The Asia-Pacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region.

IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth.

Roche diagnostics (Basel, Switzerland) is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens Healthcare(Erlangen, Germany), Abbott(Abbott Park, Illinois), Johnson and Johnson(New Jersey), Beckman Coulter(Massachusetts), Becton Dickinson(U.S.), bioMerieux (France), Bayer Diabetes(Germany), Sysmex (U.S.) and Bio-Rad(California). Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and R&D units in China to grow IVD market.

The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies.

Key Topics Covered:

1.  Executive summary 
    
2.  Introduction 
    
3.  Market Analysis 
    
4.  IVD market by Techniques 
    
5.  IVD market by Products 
    
6.  IVD market by Applications 
    
7.  IVD market by End-users 
    
8.  IVD market by Usability 
    
9.  Regional Market Analysis 
    
10. Company Developments 
    
11. Major Company Profiles 
    

--  Abbott Laboratories, Inc. 
--  Becton, Dickinson and company 
--  Biomerieux 
--  Bio-Rad Laboratories, Inc 
--  Danaher Corporation 
--  Johnson and Johnson 
--  Roche Diagnostics 
--  Siemens Healthcare 
--  Sysmex Corporation 
--  Thermo Fischer Scientific, Inc 

For more information visit http://www.researchandmarkets.com/research/mcdz7t/in_vitro

Sector: In Vitro Diagnostics

Contacts:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Keywords

Research and Markets, market research, in vitro diagnostics, poc, rapid diagnostics, marketing, forecast, ivd

Categories

Sharing

More Formats